Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dimethyl Fumarate on Cognitive Performances and Gray Matter and Thalamic Pathology in Multiple Sclerosis: a Correlation Study.

NCT05811949 is registered in ClinicalTrials.gov with IRCCS Centro Neurolesi Bonino Pulejo as lead sponsor.

NCT NCT05811949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05811949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dimethyl Fumarate on Cognitive Performances and Gray Matter and Thalamic Pathology in Multiple Sclerosis: a Correlation Study.
Lead sponsor
IRCCS Centro Neurolesi Bonino Pulejo
Phase
Observational
Overall status
Completed
Start date
February 24, 2021
Completion date
June 7, 2023
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis